SCHEDULE: Alafi Capital Reports 11.3% Stake in CalciMedica

Alafi Capital Company, LLC and Christopher D. Alafi report beneficial ownership of 11.3% of CalciMedica, Inc.'s common stock as of July 22, 2025.

Summary

• Alafi Capital Company, LLC and Christopher D. Alafi jointly filed a Schedule 13G indicating beneficial ownership of CalciMedica, Inc. common stock.
• As of July 22, 2025, the Reporting Persons beneficially own 1,583,153 shares of common stock.
• This represents 11.3% of the outstanding shares, based on 13,971,990 shares outstanding as of May 6, 2025, as reported in the company's 10-Q filing on May 14, 2025.
• Alafi Capital Company, LLC holds the shares, and Christopher D. Alafi, as the managing member, may be deemed to have sole voting and investment power over these shares.

Sentiment

Score: 6

Explanation: Neutral sentiment as the filing simply reports ownership stake without expressing positive or negative views.

Positives

• Alafi Capital's significant stake indicates confidence in CalciMedica's potential.

Future Outlook

There are no explicit forward-looking statements in this filing.

Industry Context

This filing reflects investment activity in the biotechnology sector, where companies like CalciMedica are developing novel therapies. Monitoring ownership changes can provide insights into investor sentiment and potential strategic shifts.

Comparison to Industry Standards

• Comparable companies in the biotech industry often have institutional investors holding significant stakes.
• An 11.3% stake is a notable but not uncommon level of ownership for institutional investors in similar companies.
• Other institutional investors in the biotech space include names such as BlackRock, Vanguard, and State Street, who often hold similar or larger positions in various companies.

Stakeholder Impact

• Shareholders: The disclosure of a significant ownership stake may influence investor confidence.
• Company: The company may monitor Alafi Capital's intentions and engagement.

Key Dates

Recommendation

The filing indicates a significant ownership stake by Alafi Capital, suggesting confidence in the company. However, without further information on Alafi's intentions or the company's performance, a hold recommendation is appropriate.

Keywords

CalciMedica, Alafi Capital, Christopher D. Alafi, beneficial ownership, Schedule 13G, common stock, investment